Geron (GERN) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free GERN Stock Alerts $3.79 +0.23 (+6.46%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGeron (GERN) Scheduled to Post Earnings on Thursdaymarketbeat.com - April 26 at 11:03 AMGeron to Announce First Quarter 2024 Financial Results on May 2, 2024businesswire.com - April 25 at 4:30 PMGeron (NASDAQ:GERN) Shares Up 4.6%marketbeat.com - April 24 at 6:15 PM3 Red-Hot Biotech Rockets Blasting Off in 2024investorplace.com - April 24 at 8:00 AMGeron (NASDAQ:GERN) Stock Price Down 4%marketbeat.com - April 23 at 3:44 PMGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - April 18 at 4:30 PMGeron (NASDAQ:GERN) Stock Price Up 4.7%marketbeat.com - April 17 at 11:57 AMGeron Co. (NASDAQ:GERN) Short Interest Down 8.4% in Marchmarketbeat.com - April 15 at 11:13 PMConsidering The Merits Of A Gamble On Geron Corporationseekingalpha.com - April 11 at 4:03 PMGeron (NASDAQ:GERN) Reaches New 52-Week High at $3.77marketbeat.com - April 11 at 4:01 PMBuy Rating Affirmed for Geron Following Insightful Leadership Discussion and Promising Drug Development Progressmarkets.businessinsider.com - April 11 at 3:32 PMAnalysts Offer Insights on Healthcare Companies: Carl Zeiss Meditec (GB:0DHC), Geron (GERN) and Zur Rose Group AG (Six Swiss: CH:DOCM)markets.businessinsider.com - April 11 at 10:32 AMGeron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Futurefinance.yahoo.com - April 11 at 10:32 AMGeron (NASDAQ:GERN) Stock Rating Reaffirmed by Needham & Company LLCmarketbeat.com - April 11 at 8:31 AMGeron (NASDAQ:GERN) Trading Up 2.3%marketbeat.com - April 10 at 3:24 PMGeron (NASDAQ:GERN) Rating Reiterated by Wedbushmarketbeat.com - April 10 at 1:39 PMGeron to Participate at Upcoming Investor Conferences in Aprilbusinesswire.com - April 3 at 4:30 PMGeron Co. (NASDAQ:GERN) Sees Large Growth in Short Interestmarketbeat.com - April 2 at 4:51 PMGeron (NASDAQ:GERN) Trading Up 2.2%marketbeat.com - April 2 at 12:00 PMGERN Mar 2024 3.500 putfinance.yahoo.com - March 27 at 6:48 PMWellington Management Group LLP Buys 342,493 Shares of Geron Co. (NASDAQ:GERN)marketbeat.com - March 23 at 4:07 AMWedbush Comments on Geron Co.'s Q1 2024 Earnings (NASDAQ:GERN)marketbeat.com - March 22 at 7:49 AMGeron (NASDAQ:GERN) Shares Down 4.9% marketbeat.com - March 21 at 6:43 PMWedbush Weighs in on Geron Co.'s FY2028 Earnings (NASDAQ:GERN)marketbeat.com - March 21 at 8:36 AMGeron Stock Doubles After Imetelstat Receives FDA Panel Approvalmarketbeat.com - March 20 at 6:10 AMGeron Stock Doubles After Imetelstat Receives FDA Panel Approval marketbeat.com - March 20 at 6:10 AMGeron Announces Pricing Of $150 Mln Underwritten Offering Of Common Stock, Pre-Funded Warrantsmarkets.businessinsider.com - March 19 at 2:48 PMGeron announces pricing of $150M underwritten offeringmsn.com - March 19 at 9:47 AMGeron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrantsfinance.yahoo.com - March 19 at 9:47 AMWedbush Reaffirms Outperform Rating for Geron (NASDAQ:GERN)marketbeat.com - March 18 at 6:52 PMGeron (NASDAQ:GERN) PT Raised to $5.00marketbeat.com - March 18 at 6:52 PMGERN240517C00003500 (GERN240517C00003500) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - March 18 at 1:21 PMGeron (NASDAQ:GERN) Sees Unusually-High Trading Volume on Analyst Upgrademarketbeat.com - March 18 at 10:32 AMGERN240517P00003500 (GERN240517P00003500) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - March 18 at 8:20 AMGERN Apr 2024 1.000 putfinance.yahoo.com - March 16 at 1:38 PMGERN Apr 2024 1.500 callfinance.yahoo.com - March 16 at 1:38 PMGeron Corp.wsj.com - March 16 at 1:46 AMMDGL Apr 2024 270.000 callfinance.yahoo.com - March 15 at 8:45 PMStifel Nicolaus Reaffirms Their Buy Rating on Geron (GERN)markets.businessinsider.com - March 15 at 3:37 PMGeron’s stock soars 95% after FDA advisory panel votes in favor of blood-disorder drugmsn.com - March 15 at 3:37 PMGeron (NASDAQ:GERN) Trading 3,284,900% Higher on Analyst Upgrademarketbeat.com - March 15 at 1:25 PMWhy Is Geron (GERN) Stock Up 94% Today?investorplace.com - March 15 at 10:47 AMBiggest stock movers today: ADBE, GERN, and moremsn.com - March 15 at 10:37 AMGeron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazyseekingalpha.com - March 15 at 10:37 AMGeron surges after FDA AdCom backing for lead drugmsn.com - March 15 at 10:37 AMGeron Co. (NASDAQ:GERN) Shares Bought by Walleye Capital LLCmarketbeat.com - March 15 at 5:21 AMGeron Gets Favorable Votes From FDA Panel For Imetelstat In Treating Transfusion-Dependent Anemiamarkets.businessinsider.com - March 15 at 12:36 AMCancer drug from Peninsula company wins FDA advisory committee thumbs upbizjournals.com - March 14 at 7:36 PMGeron Stock Is Soaring After Hours: What's Going On?finance.yahoo.com - March 14 at 7:36 PMGeron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDSbusinesswire.com - March 14 at 3:54 PM Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> GERN Media Mentions By Week GERN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GERN News Sentiment▼0.180.32▲Average Medical News Sentiment GERN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GERN Articles This Week▼64▲GERN Articles Average Week Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DVAX News Today LGND News Today IRWD News Today MNKD News Today INVA News Today OPK News Today FOLD News Today ORGO News Today INZY News Today FHTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GERN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Geron Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
